Unlocking the Potential Role of Decellularized Biological Scaffolds as a 3D Radiobiological Model for Low- and High-LET Irradiation.

3D model bioscaffolds high LET low LET

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
18 Jul 2024
Historique:
received: 16 06 2024
revised: 10 07 2024
accepted: 12 07 2024
medline: 27 7 2024
pubmed: 27 7 2024
entrez: 27 7 2024
Statut: epublish

Résumé

Decellularized extracellular matrix (ECM) bioscaffolds have emerged as a promising three-dimensional (3D) model, but so far there are no data concerning their use in radiobiological studies. We seeded two well-known radioresistant cell lines (HMV-II and PANC-1) in decellularized porcine liver-derived scaffolds and irradiated them with both high- (Carbon Ions) and low- (Photons) Linear Energy Transfer (LET) radiation in order to test whether a natural 3D-bioscaffold might be a useful tool for radiobiological research and to achieve an evaluation that could be as near as possible to what happens in vivo. Biological scaffolds provided a favorable 3D environment for cell proliferation and expansion. Cells did not show signs of dedifferentiation and retained their distinct phenotype coherently with their anatomopathological and clinical behaviors. The radiobiological response to high LET was higher for HMV-II and PANC-1 compared to the low LET. In particular, Carbon Ions reduced the melanogenesis in HMV-II and induced more cytopathic effects and the substantial cell deterioration of both cell lines compared to photons. In addition to offering a suitable 3D model for radiobiological research and an appropriate setting for preclinical oncological analysis, we can attest that bioscaffolds seemed cost-effective due to their ease of use, low maintenance requirements, and lack of complex technology.

Identifiants

pubmed: 39061220
pii: cancers16142582
doi: 10.3390/cancers16142582
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Alexandra Charalampopoulou (A)

CNAO National Center for Oncological Hadrontherapy, Radiobiology Unit, Research and Development Department, 27100 Pavia, Italy.
Hadron Academy PhD Course, School for Advanced Studies (IUSS), 27100 Pavia, Italy.

Amelia Barcellini (A)

Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy.
CNAO National Center for Oncological Hadrontherapy, Radiation Oncology Unit, Clinical Department, 27100 Pavia, Italy.

Andrea Peloso (A)

Division of Visceral Surgery, Department of Surgery, Geneva University Hospitals, 1205 Geneva, Switzerland.

Alessandro Vanoli (A)

Unit of Anatomic Pathology, Department of Molecular Medicine, University of Pavia, 27100 Pavia, Italy.
Unit of Anatomic Pathology, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.

Stefania Cesari (S)

Unit of Anatomic Pathology, Department of Molecular Medicine, University of Pavia, 27100 Pavia, Italy.
Unit of Anatomic Pathology, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.

Antonia Icaro Cornaglia (A)

Unit of Histology and Embryology, Department of Public Health, Experimental and Forensic Medicine, University of Pavia, 27100 Pavia, Italy.

Margarita Bistika (M)

Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, 27100 Pavia, Italy.

Stefania Croce (S)

Cell Factory, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.

Lorenzo Cobianchi (L)

Department of General Surgery, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, 27100 Pavia, Italy.
Collegium Medicum, University of Social Sciences, 90-419 Łodz, Poland.

Giovanni Battista Ivaldi (GB)

Istituti Clinici Scientific Maugeri IRCCS, Radiation Oncology Department, 27100 Pavia, Italy.

Laura Deborah Locati (LD)

Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy.
Medical Oncology Unit, Istituti Clinici Scientific Maugeri IRCCS, 27100 Pavia, Italy.

Giuseppe Magro (G)

CNAO National Center for Oncological Hadrontherapy, Medical Physics Unit, Clinical Department, 27100 Pavia, Italy.

Paola Tabarelli de Fatis (P)

Medical Physic Unit, Istituti Clinici Scientific Maugeri IRCCS, 27100 Pavia, Italy.

Marco Giuseppe Pullia (MG)

Research and Development Department, CNAO National Center for Oncological Hadrontherapy, 27100 Pavia, Italy.

Ester Orlandi (E)

CNAO National Center for Oncological Hadrontherapy, Radiation Oncology Unit, Clinical Department, 27100 Pavia, Italy.
Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, 27100 Pavia, Italy.

Angelica Facoetti (A)

CNAO National Center for Oncological Hadrontherapy, Radiobiology Unit, Research and Development Department, 27100 Pavia, Italy.

Classifications MeSH